This is an uncommon condition that is inherited and prevents the blood from clotting normally. People who have haemophilia may experience prolonged and excessive blood loss following accidents or injuries. Internal bleeding, usually in the joints, is also possible.
Babies who have haemophilia at birth are lacking in a protein known as clotting factor, which causes the blood to clot (also known as coagulation). People suffering with haemophilia have problems relating to this protein.
Haemophilia is caused by:
When the body is missing or lacking in clotting factor, this can cause the clotting process to take a prolonged amount of time, meaning that people with the condition bleed for longer following trauma or an injury.
An accident or injury triggers a response in the body which makes the blood clot to stem blood loss; this complex process is known as coagulation. This is the body's way of preventing loss of blood because if you lose a large proportion of blood, it can cause serious health problems and even death.
These are proteins which are involved in the clotting process. Clotting factors work alongside platelets (type of blood cell) to form clots and stem blood loss. When bleeding happens clotting factors cause the platelets to attach to form a blood clot at the location of the wound.
Haemophilia inhibits the normal clotting process because there is either a lack or absence of clotting factor. If the blood doesn't clot in the normal way this can cause the following problems:
In some cases, patients with haemophilia may require transfusions of clotting factors to stem blood loss.
Two core forms of haemophilia are apparent:
Haemophilia can also develop when the body makes antibodies as they attack the clotting factors – but this page will focus on inherited haemophilia.
Haemophilia can range from mild to severe and is classified according to the figure of clotting factors within the body. Figures show that around seventy percent of people who suffer with haemophilia type A have severe haemophilia. The normal percentage of clotting factor VIII is one hundred percent; however, individuals with the severe form of haemophilia type A have less than one percent.
This is a hereditary condition and is the result of a deficiency in the genes which contain the information about the production of clotting factors IX and VIII. They are situated in the X chromosome which determines the sex of a baby. Chromosomes are found in twos; two X chromosomes for women and men have one Y and one X chromosome. A female can be a haemophilia carrier and if she is in possession of this faulty gene for either clotting factor VIII or IX she can give the disorder to her child.
Female carriers for haemophilia have a:
It is not possible for men who have haemophilia to pass the condition on to a son, but all his daughters are to be carriers of the condition. If the dad has haemophilia and the mum is a carrier of the condition, a baby girl can be born with haemophilia; but this is very rare.
It is possible for a mother to give birth to a son with haemophilia if she is not a carrier, in which case the condition is brought about by a genetic mutation, rather than inheritance.
The main signs of haemophilia are bruising and blood loss.
Internal blood loss is a common symptom if people are suffering with haemophilia that is severe. If it is not treated quickly internal blood loss may result in lasting damage to the organs, tissues and even death. The amount of bleeding is heavily dependent on the condition's severity:
The first symptoms in children are usually:
Female carriers of haemophilia do not usually experience symptoms of the disorder. This is because they have sufficient sums of clotting factors by means of their healthy, normal gene.
In adults and older children the symptoms are often:
The main symptom is blood loss in the joints and can occur in the absence of injury, lasting for a number of days if left untreated. Most people with haemophilia can distinguish the symptoms of a bleed early and can seek treatment quickly, reducing the risk of permanent damage. Blood loss can affect many joints but the knees, elbows and ankles are normally affected.
Indicators of blood loss in the joints are:
If blood loss occurs in the brain it requires urgent treatment; although this is a rare it is an extremely serious threat of haemophilia. Bleeding on the brain can occur following an injury or trauma, with symptoms including:
If a doctor suspects that a patient has haemophilia they will obtain a full medical history, including details of family history, and carry out tests and a physical examination. Blood tests will also be ordered to determine:
The results of the tests will confirm whether or not an individual has haemophilia and what form of haemophilia is present. The results will also determine the severity of haemophilia. Haemophilia types A and B are categorised according to the levels of clotting factors VIII and IX:
Blood loss can arise in cases of severe haemophilia among young children. In most cases, severe haemophilia is diagnosed within the first 12 months of a baby's life, while mild and moderate cases are not identified until much later. Blood loss problems are alike for patients with both forms of haemophilia and so blood tests can confirm which type of haemophilia an individual has. It is vital for the specific type of haemophilia to be diagnosed for treatment purposes.
The most common treatment is replacement therapy and involves either the adding to or replacement of the existing clotting factor. Concentrated forms of clotting factor are injected or infused into the blood, as follows:
The form of treatment depends on the condition's severity and other factors:
If bleeding happens it is imperative to seek treatment quickly as the risk of damage increases with time. It is important for persons with haemophilia to distinguish the indicators of bleeding so they can receive treatment promptly.
Clotting factors employed in replacement therapy are derived from two supplies:
Both sources of clotting factor are safe, but lab-produced factors are typically preferred because there is no risk of viruses in human blood. Recombinant factors work in exactly the same way as clotting factors naturally found in the blood.
Initially, doses are higher than usual as only half of the action of clotting factor VIII is used within the first twelve hours and half the action of clotting factor IX is used within the first twenty-four hours. Modern clotting factors are powerful and effective and can also be stored and mixed up easily at home, which means treatment can be administered within fifteen minutes.
Replacement therapy may be administered on a routine basis to stop blood loss. This approach works on the basis that the amount of clotting factor will be high enough to avoid bleeding, usually being recommended for people who have severe haemophilia. Children may also be given preventative treatment to reduce the risk of blood loss in the joints.
Preventative replacement therapy may be used:
Preventative replacement therapy is typically administered at home, being effective but also expensive.
This form of therapy is administered to stem bleeding rapidly to prevent harm to the tissues and joints. Replacement therapy to obstruct bleeding is commonly used for individuals with moderate or mild haemophilia. The dose of clotting factor depends on several factors, including:
Replacement therapy in this case is less expensive, though a chance of blood loss prior to treatment is apparent. It is imperative that patients using this treatment become familiar with the indicators of blood loss so they can get treatment promptly. If a child has haemophilia it is beneficial for family members to learn about the symptoms of blood loss to ensure immediate treatment is sought.
Possible complications are:
Antibodies can destroy clotting factors before they have an opportunity to start working. This is a serious predicament because it renders the major treatment of haemophilia ineffective. Around 20 % of individuals with the severe type of haemophilia type A and 1 percent of individuals with haemophilia type B develop clotting factor antibodies. If this occurs doctors may increase the dose of clotting factors or use clotting factors from a different source. In some cases, clotting factor antibodies disappear and treatment can be effective.
Viruses that lead to hepatitis and AIDS (HIV) may be transmitted via clotting factors, but rigorous screening programmes are in place to reduce the risk of infection. No cases of transmission have been recorded over the last decade. Cross-infection is prevented by:
Researchers are working on new methods to make the use of donor blood even safer.
If assessment and treatment of blood loss is deferred it can cause harm to the joints and muscles. It is imperative for individuals with haemophilia to identify the early warning signs of blood loss.
Replacement therapy may be administered at home for both preventative and treatment purposes. A number of individuals learn to carry out the process and there are many advantages to this, including:
If your child suffers from haemophilia you can discuss home treatment at the doctor's office. The physician and care team will provide information and advice about the treatment method. Some people choose to have a vein access device implanted into their arm so it is simpler to access the vein; these can be useful if infusions are required on a habitual basis, though a threat of infection is apparent.
Desmopressin is a form of synthetic hormone employed to help patients with moderate or mild haemophilia type A (not used for haemophilia type B). Desmopressin encourages the freeing of clotting factor VIII as well as von Willebrand factor, which are stored in the blood vessels to increase the levels of clotting factors in the blood. The von Willebrand factor transports and will bind factor VIII to enable the protein to remain in the blood for longer. Desmopressin is usually injected but it is also available in nasal spray.
These drugs are used alongside clotting factor treatment and given to prevent the breakdown of clots. Some examples are aminocaproic acid and tranexamic acid. They are commonly used:
Parents who have a child diagnosed with the severe type of haemophilia will find this affects their daily life, and there will be changes and sacrifices they need to make. Your child's care team will be on hand to provide support and advice when your child is first diagnosed and through their childhood and teenager years.
It is completely understandable to feel worried about your child's circumstances and how it will affect their life and other family members'. You may be worried about potential cost, changes you will have to make to your personal and professional life and how the condition will impact other children you have. However, advice and support is available and it is advised to find out as much about the disorder as possible. You can do this in the following ways:
In order to prevent complications patients with haemophilia should:
It is imperative to seek urgent medical attention in the following instances:
Caring for a child with haemophilia is more difficult as they become active. As well as the regular dental/medical checks and routine immunisations, your child will also require:
As haemophilia increases the risk of bleeding and bruising, children need a very safe home environment. This means that you may need to make some changes to your home, including:
Adolescence is a tricky time for most teenagers but can be particularly challenging for those coming to terms with a lifelong condition. It is advisable as children get older to try and give them as much independence as possible, as well as ensuring support and advice is always available. It is beneficial for teenagers with haemophilia to:
Exercise has numerous benefits for physical and mental health and should be encouraged in children with haemophilia. However, exercise can increase the risk of injury and certain forms of activity are not recommended. Ask your doctor for advice about which forms of activity are safe for your children to partake in. Most types of activity are suitable for kids and adults suffering with mild haemophilia, while physical sports and activities that carry a high risk of bleeding should be off-limits for those with the severe type of haemophilia. Physiotherapists can draw-up an exercise plan for the individual and suggest suitable activities.
Examples of safe forms of exercise are:
Sports that are generally considered inadvisable are boxing, wrestling, football, hockey and rugby.
Certain medicines thin the blood and amplify the risk of bleeding, so it is vital for individuals with haemophilia to avoid the following medicines:
Home treatment has a range of benefits, including:
If receiving treatment at home it is essential to follow these precautions:
Haemophilia should not affect your ability to finish your education and pursue a career in your chosen industry.